¿Es inmunológica o un efecto adverso de otro tipo? | 19 ENE 20

Alergia a los medicamentos

¿Qué deben hacer los médicos cuando un paciente presenta un historial de "alergia a medicamentos"?
10
11
Autor/a: Robin Ferner, Patricia McGettigan Fuente: BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.l6791 The patient who reports a drug allergy
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas
  1. Lu N, Zhang Y, et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ2018;361:k2400
  2. Raas-Rothschild A, Goodman RM, Meyer S, et al. Pathological features and prenatal diagnosis in the newly recognised limb/pelvis-hypoplasia/aplasia syndrome. J Med Genet1988;25:687-97. doi:10.1136/jmg.25.10.687 pmid:3066902
  3. Smits BJ, Prior AP, Arblaster PG. Incidence of candida in hospital in-patients and the effects of antibiotic therapy. Br Med J1966;1:208-10. doi:10.1136/bmj.1.5481.208 pmid:5322596
  4. Council for International Organizations of Medical Sciences. Geneva. Reporting adverse drug reactions: definitions of terms and criteria for their use. Geneva 1999.
  5. Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA2017;318:82-3. doi:10.1001/jama.2017.6510 pmid:28672303
  6. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. Clinical guideline 2011. https://www.nice.org.uk/guidance/cg134
  7. Creamer D, Walsh SA, Dziewulski P, et al. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. http://www.bad.org.uk/shared/get-file.ashx?id=3968&itemtype=document
  8. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol2001;137:765-70.pmid:11405768
  9. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. JAMA2019;321:188-99. doi:10.1001/jama.2018.19283 pmid:30644987
  10. Raschi E, Poluzzi E, Godman B, et al. Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PLoS One2013;8:e81208
  11. White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med2018;379:1060-70. doi:10.1056/NEJMra1712125 pmid:30207919
  12. Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning. BMJ2011;342:d2218. doi:10.1136/bmj.d2218 pmid:2150804
  13. Halothane. https://livertox.nih.gov/Halothane.htm
  14. Fairley CK, McNeil JJ, Desmond P, et al. Risk factors for development of flucloxacillin associated jaundice. BMJ1993;306:233-5. doi:10.1136/bmj.306.6872.233 pmid:8443520
  15. Torpey N, Barker T, Ross C. Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrol Dial Transplant2004;19:1441-6. doi:10.1093/ndt/gfh137 pmid:15004262
  16. Shipley D, Ormerod AD. Drug-induced urticaria. Recognition and treatment. Am J Clin Dermatol2001;2:151-8. doi:10.2165/00128071-200102030-00004 pmid:11705092
  17. McPherson T, Exton LS, Biswas S, et al. British Association of Dermatologists’ guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018. Br J Dermatol2019;181:37-54. doi:10.1111/bjd.17841. pmid:30829411
  18. Watanabe H. Recent advances in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. J Immunol Res2018;2018:5163129. doi:10.1155/2018/5163129 pmid:29744372
  19. Sutter R, Rüegg S, Tschudin-Sutter S. Seizures as adverse events of antibiotic drugs: A systematic review. Neurology2015;85:1332-41. doi:10.1212/WNL.0000000000002023 pmid:26400582
  20. Hermida RC, Crespo JJ, Domínguez-Sardiña M, et al., Hygia Project Investigators. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J2019;22:754. doi:10.1093/eurheartj/ehz754 pmid:31641769
  21. National Institute for Health and Care Excellence. Drug allergy: diagnosis and management Clinical guideline. 2014. https://www.nice.org.uk/guidance/cg183
  22. Khan DA. Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests. J Allergy Clin Immunol2016;138:943-55. doi:10.1016/j.jaci.2016.08.002 pmid:27720019
  23. Roden DM, McLeod HL, Relling MV, et al. Pharmacogenomics. Lancet2019;394:521-32
  24. Phillips EJ, Bigliardi P, Bircher AJ, et al. Controversies in drug allergy: Testing for delayed reactions. J Allergy Clin Immunol2019;143:66-73. doi:10.1016/j.jaci.2018.10.030 pmid:30573342
  25. Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis1988;157:502-7. doi:10.1093/infdis/157.3.502 pmid:2449506
  26. Bateman DN, Dear JW, Thanacoody HK, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet2014;383:697-704. doi:10.1016/S0140-6736(13)62062-0 pmid:24290406
  27. Gruchalla RS, Pirmohamed M. Clinical practice. Antibiotic allergy. N Engl J Med2006;354:601-9. doi:10.1056/NEJMcp043986 pmid:16467547
  28. Jappe U. Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation?Allergy2007;62:1474-5. doi:10.1111/j.1398-9995.2007.01518.x pmid:17983386
 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2020